G. Charpentier

24.4k citations

153 papers · 6.2k indexed · 1 hit paper · h-index 41

Impact in

Endocrinology, Diabetes and Metabolism top 0.2%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes Management and Education
- Diabetes, Cardiovascular Risks, and Lipoproteins
Genetics top 1%
- Diabetes and associated disorders

Papers in

Endocrinology, Diabetes and Metabolism 104
- Diabetes Management and Research 67
- Diabetes Treatment and Management 60
- Diabetes Management and Education 20
Genetics 39
- Diabetes and associated disorders 21
- Genetic Associations and Epidemiology 9

Co-authors: Philippe Froguel Sylvia Franc Michel Marre M. Varroud‐Vial Beverley Balkau Anders G. Holst Christian Vaisse Martine Vaxillaire
Journals: Diabetes & Metabolism (21 papers)Diabetes Obesity and Metabolism (11 papers)Diabetes (9 papers)Diabetes Care (9 papers)Journal of Diabetes Science and Technology (8 papers)
Partner nations: France United Kingdom United States

In The Last Decade

G. Charpentier

150 papers receiving 6.0k citations

Hit Papers

align trajectories log scale

Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial 2017 · 438 citations

Peers

Countries citing papers authored by G. Charpentier

Since Specialization

Citations

This map shows the geographic impact of G. Charpentier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Charpentier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Charpentier more than expected).

Fields of papers citing papers by G. Charpentier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Charpentier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Charpentier. The network helps show where G. Charpentier may publish in the future.

Co-authors

The 25 scholars most cited alongside G. Charpentier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G. Charpentier Line = papers co-authored together G. Charpentier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Monoallelic pathogenic variants in LEPR do not cause obesity The American Journal of Human Genetics ·Jérôme Delplanque, L Winkelmann, Petje G, Audrey Leloire, Hyeongki Lee, Emmanuel Vaillant, G. Charpentier, Sylvia Franc, Beverley Balkau, Michel Marre, Eva Schönwald, Run-Liu Li, Mehdi Derhourhi, Philippe Froguel, Amélie Bonnefond	2024	3
2	Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas Diabetologia ·Ginger C. Vedel‐Macrander, Lidia Obama López, Raphaël Boutry, Hyeongki Lee, Emmanuel Vaillant, Aurélie Dechaume, Petje G, Beverley Balkau, G. Charpentier, Sylvia Franc, Michel Marre, Morgane Baron, Martine Vaxillaire, Mehdi Derhourhi, Mathilde Boissel, Philippe Froguel, Amélie Bonnefond	2023	4
3	Hospital stays and costs of telemedical monitoring versus standard follow-up for diabetic foot ulcer: an open-label randomised controlled study The Lancet Regional Health - Europe ·Dured Dardari, Sylvia Franc, G. Charpentier, Anna Monteiro, Hye-Lim Kang, C. Sorbara, Annarosa Gallo, 進純郎, Antônio Ermírio De Moraes, B. Detournay, Alfred Penfornis	2023	12
4	Intact Fish Skin Graft vs. Standard of Care in Patients with Neuroischaemic Diabetic Foot Ulcers (KereFish Study): An International, Multicentre, Double-Blind, Randomised, Controlled Trial Study Design and Rationale Medicina ·Dured Dardari, Louis Potier, Ariane Sultan, Y.-A Bae, J. M’Bemba, Benjamin Bouillet, Lucy Chaillous, Laurence Kessler, Aurélie Carlier, Sangeeta Persad, So Yoon Lee, Anna Monteiro, Hye-Lim Kang, B. Detournay, Steiger Hj, Santiago Castelazo, Baldur Tumi Baldursson, G. Charpentier	2022	6
5	Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes Drugs ·Stewart B. Harris, Martin J. Abrahamson, Antonio Ceriello, G. Charpentier, Marc Evans, Roger Lehmann, Andreas Liebl, Sultan Linjawi, Richard I. G. Holt, Nóra Hosszúfalusi, Guy E.H.M. Rutten, Tina Vilsbøll	2020	17
6	DIABEO System Combining a Mobile App Software With and Without Telemonitoring Versus Standard Care: A Randomized Controlled Trial in Diabetes Patients Poorly Controlled with a Basal-Bolus Insulin Regimen Diabetes Technology & Therapeutics ·Sylvia Franc, H. Hanaire, Pierre‐Yves Benhamou, Pauline Schaepelynck, Bogdan Catargi, Anne Farret, P. Fontaine, Bruno Guerci, Yves Reznik, N. Jeandidier, Alfred Penfornis, Sophie Borot, Lucy Chaillous, Pierre Sérusclat, Andreas Pistauer, Andrew Fitch, B. Detournay, Pierre Simon, G. Charpentier	2020	20
7	Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: The TeleDiab‐2 randomized controlled trial Diabetes Obesity and Metabolism ·Sylvia Franc, Michaël Joubert, Alessandra Mattiucci, C. Fagour, Pierre‐Yves Benhamou, Michel Rodier, Johannes Thesen, 久昭高橋, Pauline Schaepelynck, Bruno Guerci, Dured Dardari, Sophie Borot, Alfred Penfornis, Andrew Fitch, Karine Mari, Yves Reznik, Kwasu Tembo, G. Charpentier, (unknown)	2019	23
8	A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes Journal of Diabetes Science and Technology ·Melanie J. Davies, Steve Baín, G. Charpentier, Frank Flacke, Harmonie Goyeau, Michael Woloschak, Christoph Hasslacher, Giacomo Vespasiani, Steven V. Edelman	2019	23
9	DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial JMIR Research Protocols ·N. Jeandidier, Lucy Chaillous, Sylvia Franc, Pierre‐Yves Benhamou, Pauline Schaepelynck, H. Hanaire, Bogdan Catargi, Anne Farret, P. Fontaine, Bruno Guerci, Yves Reznik, Alfred Penfornis, Sophie Borot, Pierre Sérusclat, Andreas Pistauer, Andrew Fitch, B. Detournay, Pierre Simon, G. Charpentier	2018	13
10	A Decision Support Tool for Appropriate Glucose-Lowering Therapy in Patients with Type 2 Diabetes Diabetes Technology & Therapeutics ·Francisco Javier Ampudia‐Blasco, Pierre‐Yves Benhamou, G. Charpentier, Agostino Consoli, Michaëla Diamant, Baptist Gallwitz, Kamlesh Khunti, Chantal Mathieu, Martin Ridderstråle, Jochen Seufert, Cees J. Tack, Tina Vilsbøll, Zhou Baoshan, Herman Stoevelaar	2014	11
11	Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications Nature Genetics ·Amélie Bonnefond, Boris Skrobek, Stéphane Lobbens, Elodie Eury, Dorothée Thuillier, Stéphane Cauchi, Olivier Lantieri, Beverley Balkau, Elio Ríboli, Michel Marre, G. Charpentier, Loïc Yengo, Philippe Froguel	2013	102
12	What Is the Contribution of Two Genetic Variants Regulating VEGF Levels to Type 2 Diabetes Risk and to Microvascular Complications? PLoS ONE ·Amélie Bonnefond, Pierre‐Jean Saulnier, Maria G. Stathopoulou, Niels Grarup, Ndeye Coumba Ndiaye, Ronan Roussel, Samo Rugelj, Aurélie Dechaume, Olivier Lantieri, Serge Herçberg, Torsten Lauritzen, Beverley Balkau, Julia S. El-Sayed Moustafa, Torben Hansen, Oluf Pedersen, Philippe Froguel, G. Charpentier, Michel Marre, Samy Hadjadj, Sophie Visvikis‐Siest	2013	32
13	Télémédecine et diabète : état de l’art et perspectives Sang thrombose vaisseaux ·Sylvia Franc, Alessandra Mattiucci, Issa Jeblawi, Johannes Thesen, Núria Borrell Brau, P. (Palilingan) Palilingan, Olubunmi Alugbin, Dured Dardari, G. Charpentier	2011	2
14	Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial Diabetes Technology & Therapeutics ·Arianne C. van Bon, Bruce W. Bode, S. Calvet, J. Hans DeVries, G. Charpentier	2011	74
15	Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus Diabetes/Metabolism Research and Reviews ·André Scheen, G. Charpentier, Carl Johan Östgren, Åsa Hellqvist, Ingrid Gause‐Nilsson	2010	145
16	Earlier triple therapy with pioglitazone in patients with type 2 diabetes Diabetes Obesity and Metabolism ·G. Charpentier, S. Halimi, (unknown)	2009	24
17	Implication of the Pro12Ala polymorphism of the PPAR-gamma 2gene in type 2 diabetes and obesity in the French population BMC Medical Genetics ·Maya Ghoussaini, Stephen Eyre, Stéphane Lobbens, G. Charpentier, Karine Clément, Marie‐Aline Charles, M. Tauber, Jacques Weill, Philippe Froguel	2005	91
18	Effect of common polymorphisms in the HNF4? promoter on susceptibility to type 2 diabetes in the French Caucasian population Diabetologia ·Martine Vaxillaire, Christian Dina, Stéphane Lobbens, Aurélie Dechaume, C. TORACI, Nicole Helbecque, G. Charpentier, Philippe Froguel	2005	23
19	Effects of clinical audit on the quality of care in patients with type 2 diabetes: results of the DIABEST pilot study. PubMed ·M. Varroud‐Vial, G. Charpentier, L Vaur, JR Attali, 信男中村, Yuya Honishi, Line Kleinebreil, Claire Lévy‐Marchal, E Wolffenbuettel, Е. Багаева, É. Eschwège	2001	9
20	Manifestations cardiaques de la périartérite noueuse. Fréquence de la cardiomyopathie non hypertensive. Archives Des Maladies Du Coeur Et Des Vaisseaux ·O Blétry, P Godeau, G. Charpentier, Loı̈c Guillevin, G Herreman	1980	2

About G. Charpentier

G. Charpentier is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Surgery, Occupational Therapy and Molecular Biology, having authored 153 papers that have together received 6.2k indexed citations. Recurring topics across this work include Diabetes Management and Research (67 papers), Diabetes Treatment and Management (60 papers), Pancreatic function and diabetes (39 papers), Metabolism, Diabetes, and Cancer (28 papers), Diabetes and associated disorders (21 papers), Diabetes Management and Education (20 papers), Genetic Associations and Epidemiology (9 papers) and Mobile Health and mHealth Applications (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.7k citations), Genetics (1.5k citations), Clinical Biochemistry (311 citations), Surgery (1.8k citations) and Family Practice (78 citations). G. Charpentier has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Philippe Froguel, Sylvia Franc, Michel Marre, M. Varroud‐Vial, Beverley Balkau, Anders G. Holst, Christian Vaisse, Martine Vaxillaire, Francesco Dotta and Andrew Ahmann. Their work appears in journals such as Diabetes & Metabolism, Diabetes Obesity and Metabolism, Diabetes, Diabetes Care and Journal of Diabetes Science and Technology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact